During the past decade, Women's Specialty Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
2011-05-01
2012-05-01
Completed
990
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Women's Specialty Center
According to Clinical.Site data, the most researched conditions in "Women's Specialty Center" are
"Ovarian Cancer" (1 trials) and "Urinary Bladder, Overactive" (1 trials). Many other conditions were trialed in "Women's Specialty Center" in a lesser frequency.
Clinical Trials Intervention Types at Women's Specialty Center
Most popular intervention types in "Women's Specialty Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Fesoterodine 8 mg" (1 trials), "Placebo" (1 trials) and "oregovomab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Women's Specialty Center
The vast majority of trials in "Women's Specialty Center" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Women's Specialty Center
Currently, there are NaN active trials in "Women's Specialty Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Women's Specialty Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Women's Specialty Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".